GLP-1's pharmacy halo is lifting adjacent baskets, NMN is moving from niche to shelf, and private label supplements are winning consumer trust at the grocery checkout — rewriting winter 2026's commercial playbook.
Australia's consumer health commercial landscape shifted notably in May–June 2026. Three forces converged: the GLP-1 boom at Chemist Warehouse drove a +40% unit uplift in associated supplement baskets; NMN longevity products secured 8 SKUs at CWH with a formal exclusivity structure; and Coles' Ultralife private label won dual Product of the Year awards — confirming that grocery-shelf supplements have crossed the consumer trust threshold. These are not isolated events. They represent a fundamental repositioning of how Australians are buying health, and which channels they trust to sell it.
Longevity ingredients enter the mainstream pharmacy shelf
NMN has moved from specialist e-commerce to CWH's front-of-aisle supplement range. CellVive's Dec 2027 exclusivity signals that this is a structured commercial arrangement, not a ranging trial.
Grocery earns consumer trust in supplements
Coles Ultralife's double POY win — in adaptogens AND beauty gummies — closes the credibility gap between grocery and pharmacy in the supplement aisle. Private label in grocery is no longer a discount play; it is a premium signal.
GLP-1 users building multi-category supplement baskets
The +40% unit uplift in GLP-1-adjacent consumer health products at CWH confirms that weight-management pharmacy customers are cross-shopping into VMS, protein, and wellness supplements in a single visit.
Suppliers and brand owners who rode the NMN hype without formalising exclusivity, or who delayed TGA Permissible Indications updates, face ranging vulnerability now. The commercial window for winter 2026 immunity is open — but only to brands that are compliant, in-store, and already visible on retail media platforms before flu season peaks in July.
Longevity & Healthy Ageing (VMS)
Rising| Trending now | NMN longevity supplements; postbiotics emerging alongside probiotics at CWH |
| Consumer needs | Cellular energy, healthy ageing, longevity optimisation, anti-ageing from within |
| Ingredients / formats | NMN (nicotinamide mononucleotide); postbiotics; capsule and powder formats; premium positioning |
| Notable brands | CellVive (CWH exclusive to Dec 2027), Melrose FutureLab, BioHack Wanderlust; Blackmores (postbiotic supplier partner at CWH) |
| Pharmacy vs grocery | Firmly pharmacy-led. NMN commands $60–$120 price points unsuited to grocery. Postbiotics are beginning to surface in pharmacy editorial but have not yet ranged in grocery. |
| Seasonality / timing | No seasonal ceiling — longevity health is year-round. CWH's exclusivity structure accelerates rate-of-sale while the category is novel. |
| Commercial implication | Brands without CWH exclusivity are locked out of the market's primary NMN gateway through December 2027. Competing brands must build DTC and independent pharmacy distribution now. |
Cold / Flu / OTC Immunity
Rising| Trending now | Flu season activation: Super-K A/H3N2 variant, Healthylife 10× Rewards, CWH flu vaccination push, Codral/DURO-TUSS campaigns |
| Consumer needs | Flu prevention and treatment, symptom relief, family protection, pharmacist-led vaccination |
| Ingredients / formats | Benzydamine (Difflam Kids), OTC analgesics/decongestants; intranasal LAIV flu vaccine (new in 2026); echinacea, zinc, vitamin C in VMS immune range |
| Notable brands | Difflam Kids (Sore Throat Spray, May 2026); Codral, DURO-TUSS; Herbs of Gold 40% off at Healthylife; LAIV (Seqirus Flumist, state-funded) |
| Pharmacy vs grocery | Pharmacy leads on vaccination, OTC treatment, and high-dose immune VMS. Grocery (Healthylife) activating on mid-tier immune supplements via loyalty. Coles/Woolworths carry mainstream VMS immunity. |
| Seasonality / timing | Peak AU flu season is June–August. The Super-K variant is circulating early. Window is open now — brands not in-store by end of June miss peak demand. |
| Commercial implication | Early flu season combined with a new variant creates promotional urgency. Healthylife's 10× Rewards promotion runs to 30 June and is actively pulling category spend forward. |
Gut Health & Probiotics
Rising| Trending now | Ultra-high CFU probiotics (100B+); postbiotic education emerging at CWH; Women's Flora variant launch |
| Consumer needs | Digestive wellness, immune modulation via gut, women's intimate microbiome health, post-antibiotic recovery |
| Ingredients / formats | Multi-strain probiotics (20 strains, 100B CFU); postbiotics (heat-inactivated ferments); capsule and sachet formats |
| Notable brands | Bioglan Platinum Probiotics 100B (CWH exclusive, Women's Flora variant); Blackmores (postbiotic Fermented Whole Food range) |
| Pharmacy vs grocery | Pharmacy leads on premium high-CFU products. Grocery carries mainstream Yakult-adjacent probiotics and lower-CFU VMS. The postbiotic segment is pharmacy-exclusive for now. |
| Seasonality / timing | Autumn–winter is the natural gut/immune crossover moment. Post-cold/flu antibiotic use drives probiotic fill. Timing aligns perfectly with CWH's flu activation. |
| Commercial implication | Bioglan's 100B CFU / 20-strain positioning raises the efficacy bar for the category. Competitors with lower-potency products face a clinical communication gap at the pharmacy counter. |
Sports Nutrition
Rising| Trending now | Full-range pharmacy entry by Australian sports nutrition brands; protein + collagen convergence; greens + creatine cross-category bundling |
| Consumer needs | Muscle building, recovery, active lifestyle health, performance nutrition for mainstream gym-goers |
| Ingredients / formats | Whey/blend proteins, collagen peptides, creatine monohydrate, magnesium, greens blends; powder format dominant |
| Notable brands | BSc Body Science (full range at CWH from June 2026: protein+collagen, greens+creatine, magnesium) |
| Pharmacy vs grocery | CWH's BSc listing moves pharmacy into direct competition with supplement specialty retailers (MyProtein, Bulk Nutrients). Grocery lags significantly on sports nutrition ranging. |
| Seasonality / timing | Winter gym season; January new-year fitness intent has matured into committed habit by June. Pharmacy sports nutrition captures the health-motivated consumer who already shops CWH for VMS. |
| Commercial implication | CWH's BSc exclusivity threatens independent gym supplement retailers and specialty sports nutrition stores. Watch for competitor brands seeking similar pharmacy gateway listings at Priceline or Terry White. |
Beauty from Within & Hair
Rising| Trending now | Hair growth supplements at pharmacy; sensitive skin/eczema pharmacy entry (BEETL); women's wellness multi-benefit stacks (EZZ MeTime) |
| Consumer needs | Hair growth and retention, skin barrier repair, cortisol/stress-related beauty concerns, nail/skin/hair stacking |
| Ingredients / formats | Capixyl + Caffeine + Eucalyptus Stem Cell (EZZ Hair Shampoo); Bionap (EZZ Corti-Calm); marine collagen, biotin, keratin in gummy/capsule |
| Notable brands | EZZ Hair Growth Shampoo (CWH, Jun 2026, $25.17, Australian-made); EZZ MeTime (Corti-Calm, Hunger Helper, Muscle Relief Magnesium, May 2026); BEETL Skincare (Priceline, 205 stores, May 2026) |
| Pharmacy vs grocery | Beauty-from-within supplements straddle pharmacy and grocery. EZZ is firmly pharmacy-first. BEETL's Priceline entry confirms pharmacy leads on sensitive/clinical beauty positioning. Coles Ultralife's Hair Skin Nails POY confirms grocery is competitive in the entry segment. |
| Seasonality / timing | Autumn/winter is peak hair-loss concern season. Stress-related hair shedding (telogen effluvium) is commonly reported 3 months after high-stress periods. Post-summer hair and skin care also drives early winter demand. |
| Commercial implication | EZZ's dual-launch strategy (haircare product + wellness range simultaneously) concentrates consumer awareness spend. BEETL's immediate 205-store Priceline listing signals strong pharmacy buyer confidence in clinical-positioned skincare for sensitive/eczema consumers. |
Weight Management & GLP-1 Adjacent
Rising| Trending now | GLP-1 Rx driving consumer health basket expansion; satiety and metabolism supplements; protein-first positioning; EZZ Hunger Helper as OTC adjacent product |
| Consumer needs | Weight management support, satiety, blood sugar balance, lean muscle retention during caloric deficit, complementary support for GLP-1 users |
| Ingredients / formats | Protein (whey, collagen), fibre, chromium, berberine, satiety botanicals; high-protein RTD formats gaining traction |
| Notable brands | EZZ Hunger Helper (OTC, May 2026, pharmacy distribution June 2026); CWH GLP-1 basket cross-sell (protein + VMS) |
| Pharmacy vs grocery | Pharmacy dominates the clinical/supportive segment. GLP-1 patients are active pharmacy shoppers. Grocery plays in meal-replacement and high-protein food formats but trails on the supplement side. |
| Seasonality / timing | No strong seasonality — GLP-1 prescribing is supply-constrained, not seasonal. The basket opportunity is active year-round as GLP-1 volume at CWH continues to climb. |
| Commercial implication | Pharmacy brands that build a GLP-1 patient support stack (protein, gut support, micronutrients) and communicate it clearly to pharmacists will capture incremental basket value on every script dispensed. |
Private Label & Grocery Supplements
Rising| Trending now | Coles Ultralife double Product of Year 2026 win (Ashwagandha + Hair Skin Nails Gummies); Ultralife range expanding across marine collagen, CoQ10, sleep, liver support, vitamin D3+K2 |
| Consumer needs | Value-for-money supplements, mainstream adaptogens (ashwagandha), convenient gummy formats for daily wellness routines |
| Ingredients / formats | Ashwagandha (KSM-66), biotin/collagen/zinc in gummy, CoQ10, marine collagen, sleep (magnesium/L-theanine), vitamin D3+K2; capsule and gummy dominant |
| Notable brands | Coles Ultralife (Coles own-brand); Woolworths Macro (comparison); Aldi Specially Selected (intermittent ranging) |
| Pharmacy vs grocery | Grocery private label is the fastest-growing segment in mainstream supplements. Pharmacy private label (CWH's own-brand range) competes on price, but grocery wins on convenience channel penetration. |
| Seasonality / timing | Grocery supplement ranging resets often coincide with the new year and financial year. A mid-year Product of Year win reinforces ranging decisions and acts as a credentialing signal to casual consumers year-round. |
| Commercial implication | Supplier brands competing against Coles Ultralife must justify a $5–$12 price premium per unit. The POY win signals that retailers are embedding private label as a category anchor, not just a value alternative. Branded suppliers need stronger clinical positioning, pharmacist endorsement, or ingredients not available in private label. |
| Dimension | Pharmacy (CWH · Priceline · Terry White) | Grocery (Woolworths · Coles · Aldi) |
|---|---|---|
| Category leadership | NMN, high-CFU probiotics, GLP-1-adjacent supplements, sports nutrition, premium beauty-from-within | Mainstream VMS, ashwagandha, hair/skin/nails gummies, sleep supplements, entry-price vitamin C/D/multi |
| Private label momentum | CWH own-brand active; Priceline brand active in skincare; lower intensity in VMS supplements vs grocery | Coles Ultralife double POY win is a credentialing milestone. Woolworths Macro active. Aldi Specially Selected intermittent ranging. |
| Exclusivity & ranging | CWH NMN exclusivity (CellVive to Dec 2027); BSc Body Science sports nutrition exclusive; Bioglan 100B CFU exclusive; BEETL at Priceline 205 stores | Coles Ultralife product line breadth expanding (marine collagen, CoQ10, D3+K2, sleep, liver); grocery exclusivity rare in supplements |
| Seasonal activation | CWH flu vaccination campaigns; Difflam Kids OTC launch; Codral/DURO-TUSS OTC promotions; immunity category promotions | Healthylife (Woolworths) 10× Everyday Rewards on immunity until 30 June; Herbs of Gold 40% off; mainstream Coles immunity VMS |
| Retail media | Priceline Zitcha-powered Sponsored Search live; 9.5M loyalty member targeting; McPherson's founding partner | Woolworths media network (Cartology) and Coles 360 active; both have mature retail media platforms with health category inventory |
| Price positioning | Premium to mid-tier; NMN $60–$120; sports nutrition $40–$80; probiotics $30–$60 | Entry to mid-tier; Coles Ultralife ashwagandha ~$18–$22; hair gummies ~$15–$20; competing directly with branded entry-price products |
| Digital/loyalty | Priceline Sisterhood loyalty 9.5M members; CWH digital advertising ecosystem; pharmacist-led recommendation | Everyday Rewards (Woolworths); Flybuys (Coles); both driving personalised health supplement offers at scale |
CWH / Sigma Healthcare reported GLP-1 prescription sales growth of +16.7% year-to-date to April 2026. Critically, the associated consumer health basket — supplements, protein, and wellness products purchased alongside or after a GLP-1 script — grew +40% in units over the same period. This basket expansion is being driven by pharmacist recommendation, in-store merchandising, and GLP-1 patient awareness of complementary nutrition needs.
Chemist Warehouse has built a structured NMN longevity supplement category with 8 SKUs, anchored by an exclusivity arrangement with CellVive through December 2027. Complementary brands Melrose FutureLab and BioHack Wanderlust are also ranged. The category occupies dedicated shelf space in the healthy ageing / longevity section, reflecting CWH's strategy of category-building around high-value ingredient trends before broader pharmacy adoption.
BSc Body Science secured a full-range listing at Chemist Warehouse from June 2026, covering protein and collagen products, a greens and creatine range, and a magnesium recovery line. The listing brings mainstream sports nutrition into the pharmacy channel at scale, directly competing with specialist supplement retailers. CWH's pharmacy footprint and its GLP-1 basket opportunity make sports nutrition cross-sell highly viable alongside weight management and recovery supplement conversations.
Bioglan launched its Platinum Probiotics line at CWH — a 100 billion CFU, 20-strain probiotic in an exclusive CWH ranging arrangement, with a Women's Flora variant addressing feminine microbiome health. The 100B CFU threshold represents a significant escalation from the previous 30–50B category norm in Australia, positioning Bioglan Platinum as a clinically serious product at pharmacy counter level.
Coles Ultralife won Product of the Year 2026 in two supplement categories: Ashwagandha Tablets and Adult Hair Skin Nails Gummies — making it one of the strongest private label supplement credentialing events in Australian retail history. The Ultralife range now includes marine collagen, CoQ10, sleep support, liver health, vitamin D3+K2, and immunity products, with ongoing category expansion signalled by Coles buyers.
Sirio, a leading global gummy contract manufacturer, presented seven new TGA-compliant gummy formulation concepts at Complementary Medicines Australia's Innovation Day (21 May 2026), covering beauty, gut health, cardiovascular, metabolic health, immune support, eye health, and stress/sleep categories. All concepts are designed for the Australian regulatory pathway, reducing time-to-market for brands seeking to enter or expand gummy formats.
A/H3N2 subclade K (Super-K) is circulating earlier than historical norms in 2026 across eastern Australia. Healthylife responded with a 10× Everyday Rewards points promotion on immunity products until 30 June, with Herbs of Gold at 40% off. CWH is running flu vaccination campaigns and Codral/DURO-TUSS OTC campaigns are active. Peak flu season typically hits July–August, meaning the early activation window is advantageous for brands already in-store.
Reckitt launched Difflam Kids Sore Throat Spray in May 2026 — a benzydamine-based topical sore throat treatment formulated for children 6 years and over, priced at $14.99 and ranging across CWH, Priceline, Coles, and Terry White Chemists. The launch fills a pharmacy gap for paediatric topical sore throat relief ahead of peak flu season. Benzydamine provides both analgesic and anti-inflammatory action directly at the throat mucosa.
EZZ launched its MeTime women's wellness range in May 2026 — three products: Corti-Calm (featuring Bionap botanical extract for cortisol modulation), Hunger Helper (satiety support, OTC positioning), and Muscle Relief Magnesium (recovery). Pharmacy distribution is scheduled from June 2026. The range targets stress-driven beauty and body concerns, linking cortisol with weight, skin, and hair outcomes — a narrative strongly active in social and search health media.
EZZ's Hair Growth Shampoo launched at CWH on 2 June 2026 at $25.17, featuring Capixyl (a patented hair growth peptide), caffeine, and Eucalyptus Stem Cell. The product is Australian-made, a provenance claim that resonates with pharmacy consumers. Capixyl has published clinical efficacy data, giving the product a pharmacist-recommendation pathway beyond typical shampoo conversations.
BEETL Skincare, a New Zealand clinical derma brand, listed at Priceline across 205 stores from 11 May 2026. The range targets sensitive skin, eczema-prone skin, and baby skincare — a segment where consumers strongly prefer pharmacist recommendation. BEETL's NZ clinical credentials and formulation philosophy align with Priceline's growing focus on clinical skin health beyond traditional beauty.
CWH published consumer education content on 4 May 2026 introducing postbiotics ("You've Heard of Probiotics, But Have You Heard of Postbiotics?"), with Blackmores as the supplier partner. Postbiotics — the bioactive compounds produced by probiotic bacteria — represent the next evolution of the gut health category, offering greater stability and shelf-life vs live probiotic cultures. CWH's editorial push typically precedes formal product ranging by 4–8 weeks.
Priceline has launched a full retail media network powered by Zitcha, with Sponsored Search now live against its 9.5 million Priceline Sisterhood loyalty members. McPherson's is the founding advertising partner — one of Australia's leading health, beauty and wellness distribution companies. The network enables targeted health and beauty advertising at the point of purchase, with loyalty-data audience segmentation.
Healthylife (Woolworths' online health platform) is running a 10× Everyday Rewards points promotion on immunity-category products until 30 June 2026. Herbs of Gold is featured at 40% off. The promotion targets the pre-peak flu season window, using loyalty incentives to drive trial and basket fill before peak pharmacy flu season competition intensifies in July.
Australia introduced the intranasal Live Attenuated Influenza Vaccine (LAIV) in 2026 for children aged 2–17 years — the first needle-free flu vaccine option available domestically. NSW, QLD, SA, and WA are providing state-funded LAIV for children under 5 years. The needle-free format significantly reduces the hesitancy barrier for paediatric flu vaccination and is expected to increase overall childhood flu vaccination rates through pharmacy and GP channels.
The TGA's Permissible Indications transition for listed complementary medicines closed on 5 March 2026. Listed medicine sponsors who failed to update their ARTG entries to the new permissible indications framework have had those entries cancelled. This represents a significant regulatory compliance event — any product currently on shelf that was not updated is now technically unlawful to supply. Category-wide non-compliance risk remains elevated as enforcement catches up.
The TGA removed four listed complementary medicine products from the ARTG following a post-market review of Vitamin D bone strength claims. The removals were linked to insufficient evidence supporting specific bone health claim combinations. This follows TGA's ongoing use of post-market surveillance to enforce evidence standards for listed medicine health claims.
The magnesium glycinate segment within the broader magnesium category is growing at a faster rate than the overall category, with powder formats — dissolvable, flavoured sleep-and-stress blends — driving volume. Switch Nutrition, Herbs of Gold, and Blackmores are all active in this format. The powder format aligns with social media rituals ("night drink" or "evening wind-down" trends) and commands a price premium over traditional tablet magnesium.
Coles Ultralife Ashwagandha Tablets' Product of the Year 2026 win formally validates ashwagandha's crossover from pharmacy adaptogen to mainstream grocery supplement. The recognition demonstrates that grocery shoppers are actively selecting and repurchasing ashwagandha — a market signal that the category has passed the novelty phase and entered everyday wellness purchasing behaviour at the grocery checkout.
Chemist Warehouse signed a Memorandum of Understanding with GreenLight Healthcare to open its first UK stores, with Hoxton Street, London as the flagship location and a Phase 1 target of up to 5 stores. The CWH UK model will replicate the high-volume, low-price pharmacy model that disrupted Australian retail pharmacy. UK market entry positions CWH as an international retail pharmacy brand and signals ambition well beyond the Australian domestic market.
GLP-1 Patient Supplement Stack — Build the Pharmacist-Recommended Bundle at CWH
The +40% GLP-1 adjacent supplement basket at CWH is not being served by a coordinated brand narrative. The first brand to develop and communicate a pharmacist-validated "GLP-1 support stack" — protein, gut support, magnesium, B-vitamins, and satiety — will capture the basket compounding effect. This is an immediate commercial opportunity at the world's highest-volume pharmacy retailer.
Winter Immunity Bundle — Early Season Capture Before Peak July Competition
The Super-K A/H3N2 variant is circulating earlier than historical norms. Brands with immunity supplements — zinc, elderberry, echinacea, vitamin C, and high-CFU probiotics — that are in-store and on promotion by end of June will capture early-wave demand before peak competition in July. Healthylife's 10× Rewards mechanic provides an additional loyalty-driven demand pull through the end of June.
Gummy Format Expansion Across Multiple Categories — Sirio's TGA-Ready Pipeline
Sirio's CMA Innovation Day presentation of 7 TGA-compliant gummy concepts across beauty, gut, cardiovascular, metabolic, immune, eye health, and sleep categories means the formulation pathway is already open. Brand owners who move quickly into Sirio's pipeline across 2–3 of these categories can launch premium, TGA-registered gummy products in H2 2026 — ahead of the expected wave of competitor launches in 2027.
Postbiotic First-Mover in AU Pharmacy — Ahead of the CWH Ranging Activation
CWH published consumer postbiotic education content on 4 May 2026 — an editorial signal that typically precedes formal category ranging by 4–8 weeks. Brands with TGA-registered postbiotic formulations should be in active ranging conversations with CWH buyers now. The first brand to secure pharmacy shelf space in the postbiotic segment will define the category and set pricing architecture before competition enters.
Priceline Retail Media Early Adopter — Sponsor Search Before CPCs Mature
Priceline's Zitcha-powered retail media network is newly live with Sponsored Search across 9.5 million loyalty members. Cost-per-click rates are lowest at network launch and rise as more advertisers enter. Health, beauty, and personal care brands listed at Priceline should activate Sponsored Search campaigns immediately to establish share of voice and algorithmic position before the network matures and CPCs increase materially.
| Trend | AU Visibility | Entry Channel | Barriers | Timing |
|---|---|---|---|---|
| CWH UK Expansion (GreenLight Healthcare MoU) | Confirmed AU Active — MoU signed, Hoxton St London as first store, Phase 1 up to 5 stores | International pharmacy retail — AU brand export opportunity via CWH UK | UK MHRA regulatory clearance for listed medicines; UK consumer pricing expectations; logistics; brand awareness build from zero | Immediate — CWH UK store opening imminent |
| Ozempic Face / GLP-1 Body Composition Aesthetics (US) | Watch Not yet an AU retail trend but US social and clinical media is driving consumer awareness | Premium pharmacy, derma clinic, medical aesthetics | TGA does not permit GLP-1 adjacency in OTC claims; consumer-level awareness of GLP-1 body/face effects is lower in AU than US; cultural framing differences | 12–18 months to AU retail relevance; monitor US beauty media for leading indicators |
| Postbiotics — US / European Category Build (Pendulum, WholoBiome) | Early AU CWH blog content (4 May 2026) is the first formal AU consumer education signal; no confirmed retail ranging yet | Premium pharmacy; Healthylife online; practitioner channel | TGA has no formal postbiotic definition; "postbiotic" label claims need TGA pre-market advice; Australian consumer education still early-stage | 4–8 weeks to first AU pharmacy ranging if brands are ready; 12 months to mainstream grocery |
| Taurine Longevity Supplement Wave (US — Science 2023 landmark study) | Early AU No AU retail movement yet; small DTC/practitioner visibility; US taurine supplement sales +180% post-study | Online DTC, independent pharmacy; ultimately mainstream pharmacy if clinical narrative builds | Taurine is not an unusual ingredient — low TGA barrier — but no clinical positioning at AU retail yet; low consumer awareness; competing with established magnesium and B-vitamin supplement spend | 6–12 months if US momentum continues; watch for brand launches at naturalproductsexpo.com or CHFA |
| Creatine Beyond Sports — Female Wellness and Cognitive Health Positioning (US / UK) | Early AU Signal BSc Body Science's greens+creatine CWH listing bridges sports and mainstream wellness; no female-specific creatine products at AU retail yet | Pharmacy sports nutrition; mainstream pharmacy VMS; online | Creatine's gender-neutral and cognitive positioning narrative is not yet established at AU retail; female consumer adoption requires targeted communication strategy beyond gym-specific channels | 6–12 months for female wellness creatine products to emerge at AU pharmacy; watch UK sports nutrition brands entering AU |
| Functional Beauty Ingestibles — UK / US Prestige Channel (MAELYS, HUM Nutrition, Gold Collagen) | Early AU Prestige beauty supplements very limited in AU retail; BEETL's Priceline listing is closest signal in clinical skin positioning | Premium pharmacy, Mecca, department store beauty, Priceline premium tier | AU consumers less familiar with prestige-positioned ingestible beauty; higher price points ($60–$150 per month) than current AU pharmacy collagen/biotin entry level; regulatory labelling for cosmetic vs therapeutic claims | 12–24 months to AU retail mainstream; monitor Mecca and Sephora AU for early listings |
- Audit your full ARTG portfolio for TGA Permissible Indications compliance now — cancelled entries create ranging vulnerability and regulatory exposure.
- Decide whether your core market is pharmacy (clinical, premium, exclusive) or grocery (value, accessible, mainstream) — competing in both without differentiation risks margin compression and channel conflict.
- If you have a GLP-1 adjacent supplement, build a pharmacist-validated product narrative that avoids impermissible mechanism claims but captures the basket opportunity at CWH.
- If you have a postbiotic or NMN formulation, engage CWH buyers immediately — the ranging windows for these categories are open and time-sensitive.
- Develop a GLP-1 patient supplement recommendation protocol for pharmacists — the +40% basket uplift is not self-sustaining without structured recommendation.
- Ensure your immunity and OTC cold/flu ranges are fully stocked and promoted before end of June — the Super-K early season creates demand pull that pre-July promotional plans may miss.
- Activate Priceline retail media Sponsored Search early — first-mover CPCs are lowest now and flu season creates peak search intent for health products.
- Build a winter family self-care kit narrative around LAIV paediatric vaccination cross-sell with family probiotics and vitamin C.
- Coles Ultralife's double POY win is a ranging and ranging-reset asset — use it in buyer negotiations with branded supplement suppliers to reset margin expectations.
- Expand Ultralife into postbiotics, magnesium glycinate powders, and NMN once CWH exclusivity expires — these are the next mainstream supplement categories.
- Healthylife's 10× Rewards immunity mechanic should be replicated for the winter gut health and sleep supplement categories — the loyalty data exists to target the right shopper.
- Watch BSc Body Science CWH listing carefully — if sports nutrition proves successful at pharmacy, Woolworths and Coles will need a competing sports nutrition ranging strategy by mid-2027.
- Track GLP-1 pharmacy basket data quarterly — the composition of the GLP-1 adjacent basket (which supplement categories are most commonly cross-purchased) will define new product development priorities for 2027 and beyond.
- Monitor postbiotic consumer awareness via search and social data — when awareness crosses the 15% threshold in Australia, mainstream pharmacy ranging will accelerate rapidly.
- Develop a private label supplement competitive index — tracking Coles Ultralife and Woolworths Macro ingredient quality, pricing, and ranging expansion is now as strategically important as tracking major branded competitors.
- Model the NMN post-exclusivity scenario (post-Dec 2027) for category sizing, pricing architecture, and brand entry/exit scenarios.
- CWH's GLP-1 Rx volume (+16.7% YTD) combined with +40% adjacent supplement basket growth represents a material revenue compounding effect that is likely to accelerate as GLP-1 supply constraints ease.
- Coles Ultralife's credentialing milestone is a leading indicator of grocery becoming a structurally larger share of the AU supplement market — this changes the competitive landscape and margin outlook for branded supplement suppliers across the next 3–5 years.
- NMN longevity supplement category in AU is pre-commercialisation — the post-Dec 2027 open market will be the key investment window for brands seeking NMN category positions at scale.
- CWH UK expansion (GreenLight Healthcare MoU) introduces an international revenue dimension to an otherwise domestic Australian retail pharmacy investment thesis.
Ride the GLP-1 Halo — But With Compliant, Pharmacist-Led Narratives
The GLP-1 basket opportunity at CWH is the single highest-value commercial activation available to supplement brands in Australian pharmacy right now. But the mechanism is pharmacist recommendation — not consumer marketing that implies OTC GLP-1 equivalence. The winning strategy is a clearly defined "GLP-1 patient support" product set (protein, gut health, electrolytes, B-complex, satiety fibre) with a pharmacist education programme that positions these supplements as clinically appropriate co-interventions — not pharmaceutical alternatives. Brands that activate this with CWH pharmacists before competitors arrive will own the cross-sell narrative.
Own a Category-Defining Ingredient Before Exclusivity Matures
CWH's strategy of building exclusive brand relationships in high-value ingredient categories (NMN, BSc sports, Bioglan 100B probiotics) creates first-mover monopoly positions at scale. The lesson for brands is clear: bring a category-defining ingredient narrative to CWH with exclusivity terms before a competitor does. Postbiotics, taurine longevity, magnesium glycinate powder formats, and creatine female wellness are the categories where exclusive category arrangements are still possible in 2026. Brands with ready formulations in these areas should be in CWH buyer conversations now.
Build Differentiation That Private Label Cannot Buy
Coles Ultralife's double POY win closes the perception gap on ingredient quality for mainstream supplement categories. The competitive moats that private label genuinely cannot replicate are: clinical evidence (published RCTs, efficacy data), branded ingredient provenance (KSM-66, Verisol, Longvida curcumin), pharmacist endorsement, therapeutic goods advertising approval, and specialist practitioner recommendation. Brands competing in ashwagandha, hair/skin/nails, collagen, or sleep categories without at least two of these differentiators are at serious ranging risk as Coles and Woolworths extend Ultralife and Macro into more supplement categories.
Activate Winter Flu Season Now — Early Wave Demands Pre-July Visibility
Super-K's early circulation in 2026 has moved the commercial flu season window forward by 3–4 weeks. Brands with immunity supplements — echinacea, elderberry, zinc, vitamin C, high-CFU probiotics, and OTC cold/flu products — that are in-store, on promotion, and on Priceline's Sponsored Search before the end of June will capture the early wave. Brands relying on July promotional placements will face peak competition with less upside available. The single highest-ROI action for immunity brands right now is activating Healthylife's 10× Rewards programme, booking Priceline Sponsored Search, and confirming CWH promotional activity before 30 June.
Treat Gummy Format as a Strategic Platform, Not a Tactic
Sirio's 7 TGA-compliant gummy concepts across 7 categories signal that gummy format innovation is now infrastructure, not novelty. For brands that have not launched a gummy SKU, the strategic question is no longer whether gummies are appropriate — they are — but which categories to enter first and how to differentiate on taste, dose, and ingredient provenance within a format that is becoming commoditised. The brands that will win in gummies are not those who launch fastest but those who build the best consumer ritual experience (flavour, texture, packaging) and the most credible clinical story. This is a 24-month window before the gummy category becomes fully crowded at every retailer.
Pharmacy is consolidating premium supplement authority. The combination of CWH's NMN exclusivity, Bioglan's 100B probiotic exclusive, BSc sports nutrition entry, and Priceline's live retail media platform means pharmacy is pulling away from grocery on new product velocity and premium category development. Pharmacist-backed recommendation and clinical credentialing are advantages grocery cannot easily replicate.
Grocery is winning on value, format, and accessibility. Coles Ultralife's double POY win is not a fluke — it reflects a deliberate range build across 10+ supplement categories that now competes credibly on ingredient quality (KSM-66 ashwagandha, marine collagen) at price points 30–50% below branded equivalents. For cost-conscious first-time supplement buyers, grocery is the most accessible trial channel.
The strategic implication for brand owners is channel clarity. Brands trying to win in both channels simultaneously face margin compression and retailer conflict. The clearest path is category-specific positioning: own a premium clinical story at pharmacy, or own a value-at-scale story at grocery — not both. The middle ground is increasingly owned by retailer private label.